A Trial of Text-Message-Based Engagement for Well-Child Visits

NCT06698640 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2821

Last updated 2026-01-13

No results posted yet for this study

Summary

The goal of this clinical trial is to evaluate the effectiveness of different outreach strategies in closing HEDIS gaps for Well-Child Visits (WCV) in children aged 0-21 years. The main questions it aims to answer are:

Does automated SMS outreach improve the rate of completed Well-Child Visits compared to traditional passive outreach? Does the combination of automated SMS and appointment scheduling assistance lead to higher completion rates than automated SMS alone?

Researchers will compare three groups to see if the different outreach strategies have varying effects on WCV completion rates:

Control Group: Participants will receive traditional passive outreach (current standard practice).

Automated SMS Group: Participants will receive standardized SMS messages to remind them of their Well-Child Visits.

Automated SMS + Scheduling Assistance Group: Participants will receive SMS messages along with proactive assistance in scheduling their appointments.

Participants will:

Be randomized into one of the three study groups. Receive outreach according to their group assignment. Have their appointment scheduling and attendance tracked. Contribute data that will help evaluate the effectiveness of each outreach strategy in closing HEDIS gaps for Well-Child Visits.

This study aims to optimize outreach methods to improve healthcare delivery and preventive care adherence for pediatric populations.

Conditions

  • Well Child Visit
  • Gaps in Care

Interventions

BEHAVIORAL

Automated SMS

Participants will receive automated SMS messages reminding them of their Well-Child Visits. These messages will be standardized and sent at intervals designed to prompt appointment attendance.

BEHAVIORAL

Automated SMS + Scheduling Assistance

Participants will receive the same automated SMS messages as in Arm 2, but with the added component of proactive appointment scheduling assistance. This may include options for scheduling directly through the SMS platform or follow-up messages encouraging appointment setting.

Sponsors & Collaborators

  • Waymark

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
0 Years
Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-09
Primary Completion
2025-12-31
Completion
2026-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06698640 on ClinicalTrials.gov